TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $90,000 | +181.2% | 1,193 | 0.0% | 0.00% | – |
Q1 2022 | $32,000 | -97.5% | 1,193 | -95.6% | 0.00% | -100.0% |
Q4 2021 | $1,295,000 | -13.0% | 27,151 | +21.1% | 0.00% | 0.0% |
Q3 2021 | $1,489,000 | -14.9% | 22,424 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,749,000 | +8.3% | 22,424 | +31.4% | 0.00% | -50.0% |
Q1 2021 | $1,615,000 | -10.0% | 17,068 | +15.9% | 0.00% | -33.3% |
Q4 2020 | $1,794,000 | +56.1% | 14,724 | +12.0% | 0.00% | +50.0% |
Q3 2020 | $1,149,000 | +1432.0% | 13,152 | +1030.9% | 0.00% | – |
Q2 2020 | $75,000 | – | 1,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |